awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36508630-4191B1F9-B7A5-4364-9D5D-FC34886C39C2
Q36508630-4191B1F9-B7A5-4364-9D5D-FC34886C39C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36508630-4191B1F9-B7A5-4364-9D5D-FC34886C39C2
Advances in paediatric cancer treatment
P2860
Q36508630-4191B1F9-B7A5-4364-9D5D-FC34886C39C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36508630-4191B1F9-B7A5-4364-9D5D-FC34886C39C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b2f0ec9ac6d212e67e46e4be548a2d1df180c40
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).